When the first question made its way down the panel to Brook Byers (of Kleiner, Perkins, Caufield & Byers), he momentarily ignored the topic at hand to posit: “In a room full of Biodesign Alumni, my hunch is there are a lot of people in here with an engineering or science background.”
Following some nods throughout the audience, he lurched into what can only be described as a good old-fashioned Higgs Boson joke: “So a Higgs Boson walks into a Catholic Church, and the Priest says, ‘We don’t allow your kind in here!’”
The Innovations in Cardiovascular Interventions (ICI) Meeting, held in Israel every year, is an internationally renowned conference bringing together clinicians, researchers, and industry to provide a wide perspective on new technologies in the field of cardiology and cardiovascular surgery. Led by Prof. Chaim Lotan and Prof. Rafael Beyar, It is regularly attended by over 700 attendees from more than 40 countries. The next meeting will be held in Tel-Aviv at the David Intercontinental Hotel from Dec. 14-16.
Trade-offs drive success, conviction drives success, and team drives success.
Duke Rohlen closed our Biodesign Alumni Annual Event with this quip and it provides a great summary of the CV Ingenuity (CVI) story. As CEO and president, Duke was joined by CFO Doug Koo and NEA investor Justin Klein for a panel discussion that highlighted the company’s path. Read more
When Dr. Thomas Fogarty is in the office, he holds meetings all day long. Not unlike the President, he is briefed moments before every meeting. With each new visitor, he brings a fresh enthusiasm to the table, an eagerness to listen and to be impressed. Everybody gets a fair shot, and many are successful—unless, of course, they commit a cardinal sin. Read more
The medtech industry is built upon the ideas of creative physicians thinking outside the box; here’s advice from a modern-day physician-innovator.
Given their understanding of disease and pathophysiology, innovative physicians have been the source for many of the major technology advancements throughout the history of medicine. Although commercializing medical technologies today has become more complex than ever – physician still play a vital role in conceiving new products and getting them to patients.
Todd Alamin, MD, an Associate Professor of Orthopaedic Surgery at Stanford University and serial medical device entrepreneur (founder of InnoSpine, acquired by Kyphon; and Simpirica), recently sat down with the Biodesign Alumni group to discuss his experiences being involved in both clinical practice and medical device entrepreneurship. From a deep personal history of combining medtech innovation and clinical practice specializing in spine surgery, Todd was able to provide insights into what makes for a successful physician-innovator. Read more